Using patients as their own controls for cost evaluation of phase I clinical trials
Cancer Care Facilities
Clinical Trials, Phase I as Topic
Health Care Costs
Using patients as their own controls represents a new, efficient method for evaluating the cost of phase I trials, and it warrants further study. The results of our pilot study do not suggest that phase I trials always cost payers more than standard treatment.